Patient Derived Xenograft Models Market 2028 By Product Type, Tumor Type, Application, End-Users and Geography | The Insight Partners

Patient Derived Xenograft Models Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Mice Models, Rat Models.); Tumor Type (Gastrointestinal Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Hematological Tumor Models, Other Tumor Models); Application (Preclinical Drug Development, Biomarker Analysis, Basic Cancer Research.); End-Users (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutions.) and Geography

Report Code: TIPRE00021693 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET INTRODUCTION

Patient-derived xenografts models are the models of cancer in which the cells or tissue are implanted from a patient's tumor into an immune-deficient mouse. PDX model offers the translational preclinical model for efficacy screening in cancer drug development for cancer, diabetes, infections, etc. PDX model has demonstrated advantages in biomarker growth and co-clinical studies. These models reflect the human patient population heterogeneity and diversity. PDX models have higher predictive values for clinical outcomes than any other model.

MARKET DYNAMICS

The patient-derived xenograft models market growth is driven mainly due to rising personalized medicine demand, growing research & development activities in the pharmaceutical industry, increasing burden of cancer, and continuous support for cancer research. Moreover, increasing demand for humanized PDX models and improved healthcare infrastructure is expected to propel the market growth. Due to the Covid-19 pandemic, the patient-derived xenograft models market experienced reduced productivity, reduced research and development activities, and disrupted clinical trials. In contrast, the high cost of models and required drugs and stringent guidelines considering ethical animal use in cancer research are factors that may restrain the growth of the patient-derived xenograft models market.

MARKET SCOPE

The "Patient Derived Xenograft Models Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of patient derived xenograft models market with detailed market segmentation by product type, tumor type, application and end-users. The patient derived xenograft models market are expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in patient derived xenograft models market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The patient derived xenograft models market are segmented on the basis of product type, tumor type, application and end-users. On the basis of product type, the market is segmented into mice models, and rat models. On the basis of tumor type, the market is segmented as gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, hematological tumor models, and other tumor models. On the basis of application, the market is segmented into preclinical drug development, biomarker analysis, and basic cancer research. On the basis of end-users, the market is segmented into pharmaceutical & biotechnology companies, contract research organizations (CROs), and academic & research institutions.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the patient derived xenograft models market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The patient derived xenograft models market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting patient derived xenograft models market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the patient derived xenograft models market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the patient derived xenograft models market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from patient derived xenograft models market are anticipated to have lucrative growth opportunities in the future with the rising demand for patient derived xenograft models in the global market. Below mentioned is the list of few companies engaged in the patient derived xenograft models market.

The report also includes the profiles of key players in patient derived xenograft models market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Crown Bioscience Inc.
  •  WuXi AppTec
  •  Champions Oncology, Inc.
  •  The Jackson Laboratory
  •  Oncodesign
  •  Charles River Laboratories International, Inc.
  •  EPO Berlin-Buch GmBH
  •  Shanghai LIDE Biotech Co., Ltd
  •  Xentech
  •  Envigo

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Patient Derived Xenograft Models Market - By Product Type
1.3.2 Patient Derived Xenograft Models Market - By Tumor Type
1.3.3 Patient Derived Xenograft Models Market - By Application
1.3.4 Patient Derived Xenograft Models Market - By End-Users
1.3.5 Patient Derived Xenograft Models Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PATIENT DERIVED XENOGRAFT MODELS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PATIENT DERIVED XENOGRAFT MODELS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PATIENT DERIVED XENOGRAFT MODELS MARKET - GLOBAL MARKET ANALYSIS
6.1. PATIENT DERIVED XENOGRAFT MODELS - GLOBAL MARKET OVERVIEW
6.2. PATIENT DERIVED XENOGRAFT MODELS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. PATIENT DERIVED XENOGRAFT MODELS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. MICE MODELS
7.3.1. Overview
7.3.2. Mice Models Market Forecast and Analysis
7.4. RAT MODELS.
7.4.1. Overview
7.4.2. Rat Models. Market Forecast and Analysis
8. PATIENT DERIVED XENOGRAFT MODELS MARKET - REVENUE AND FORECASTS TO 2028 - TUMOR TYPE
8.1. OVERVIEW
8.2. TUMOR TYPE MARKET FORECASTS AND ANALYSIS
8.3. GASTROINTESTINAL TUMOR MODELS
8.3.1. Overview
8.3.2. Gastrointestinal Tumor Models Market Forecast and Analysis
8.4. GYNECOLOGICAL TUMOR MODELS
8.4.1. Overview
8.4.2. Gynecological Tumor Models Market Forecast and Analysis
8.5. RESPIRATORY TUMOR MODELS
8.5.1. Overview
8.5.2. Respiratory Tumor Models Market Forecast and Analysis
8.6. UROLOGICAL TUMOR MODELS
8.6.1. Overview
8.6.2. Urological Tumor Models Market Forecast and Analysis
8.7. HEMATOLOGICAL TUMOR MODELS
8.7.1. Overview
8.7.2. Hematological Tumor Models Market Forecast and Analysis
8.8. OTHER TUMOR MODELS
8.8.1. Overview
8.8.2. Other Tumor Models Market Forecast and Analysis
9. PATIENT DERIVED XENOGRAFT MODELS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. PRECLINICAL DRUG DEVELOPMENT
9.3.1. Overview
9.3.2. Preclinical Drug Development Market Forecast and Analysis
9.4. BIOMARKER ANALYSIS
9.4.1. Overview
9.4.2. Biomarker Analysis Market Forecast and Analysis
9.5. BASIC CANCER RESEARCH.
9.5.1. Overview
9.5.2. Basic Cancer Research. Market Forecast and Analysis
10. PATIENT DERIVED XENOGRAFT MODELS MARKET - REVENUE AND FORECASTS TO 2028 - END-USERS
10.1. OVERVIEW
10.2. END-USERS MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
10.4. CONTRACT RESEARCH ORGANIZATIONS (CROS)
10.4.1. Overview
10.4.2. Contract Research Organizations (CROs) Market Forecast and Analysis
10.5. ACADEMIC AND RESEARCH INSTITUTIONS.
10.5.1. Overview
10.5.2. Academic and Research Institutions. Market Forecast and Analysis

11. PATIENT DERIVED XENOGRAFT MODELS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Patient Derived Xenograft Models Market Overview
11.1.2 North America Patient Derived Xenograft Models Market Forecasts and Analysis
11.1.3 North America Patient Derived Xenograft Models Market Forecasts and Analysis - By Product Type
11.1.4 North America Patient Derived Xenograft Models Market Forecasts and Analysis - By Tumor Type
11.1.5 North America Patient Derived Xenograft Models Market Forecasts and Analysis - By Application
11.1.6 North America Patient Derived Xenograft Models Market Forecasts and Analysis - By End-Users
11.1.7 North America Patient Derived Xenograft Models Market Forecasts and Analysis - By Countries
11.1.7.1 Canada Patient Derived Xenograft Models Market
11.1.7.1.1 Canada Patient Derived Xenograft Models Market by Product Type
11.1.7.1.2 Canada Patient Derived Xenograft Models Market by Tumor Type
11.1.7.1.3 Canada Patient Derived Xenograft Models Market by Application
11.1.7.1.4 Canada Patient Derived Xenograft Models Market by End-Users
11.1.7.2 Mexico Patient Derived Xenograft Models Market
11.1.7.2.1 Mexico Patient Derived Xenograft Models Market by Product Type
11.1.7.2.2 Mexico Patient Derived Xenograft Models Market by Tumor Type
11.1.7.2.3 Mexico Patient Derived Xenograft Models Market by Application
11.1.7.2.4 Mexico Patient Derived Xenograft Models Market by End-Users
11.1.7.3 US Patient Derived Xenograft Models Market
11.1.7.3.1 US Patient Derived Xenograft Models Market by Product Type
11.1.7.3.2 US Patient Derived Xenograft Models Market by Tumor Type
11.1.7.3.3 US Patient Derived Xenograft Models Market by Application
11.1.7.3.4 US Patient Derived Xenograft Models Market by End-Users
11.2. EUROPE
11.2.1 Europe Patient Derived Xenograft Models Market Overview
11.2.2 Europe Patient Derived Xenograft Models Market Forecasts and Analysis
11.2.3 Europe Patient Derived Xenograft Models Market Forecasts and Analysis - By Product Type
11.2.4 Europe Patient Derived Xenograft Models Market Forecasts and Analysis - By Tumor Type
11.2.5 Europe Patient Derived Xenograft Models Market Forecasts and Analysis - By Application
11.2.6 Europe Patient Derived Xenograft Models Market Forecasts and Analysis - By End-Users
11.2.7 Europe Patient Derived Xenograft Models Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Patient Derived Xenograft Models Market
11.2.7.1.1 Germany Patient Derived Xenograft Models Market by Product Type
11.2.7.1.2 Germany Patient Derived Xenograft Models Market by Tumor Type
11.2.7.1.3 Germany Patient Derived Xenograft Models Market by Application
11.2.7.1.4 Germany Patient Derived Xenograft Models Market by End-Users
11.2.7.2 France Patient Derived Xenograft Models Market
11.2.7.2.1 France Patient Derived Xenograft Models Market by Product Type
11.2.7.2.2 France Patient Derived Xenograft Models Market by Tumor Type
11.2.7.2.3 France Patient Derived Xenograft Models Market by Application
11.2.7.2.4 France Patient Derived Xenograft Models Market by End-Users
11.2.7.3 Italy Patient Derived Xenograft Models Market
11.2.7.3.1 Italy Patient Derived Xenograft Models Market by Product Type
11.2.7.3.2 Italy Patient Derived Xenograft Models Market by Tumor Type
11.2.7.3.3 Italy Patient Derived Xenograft Models Market by Application
11.2.7.3.4 Italy Patient Derived Xenograft Models Market by End-Users
11.2.7.4 Spain Patient Derived Xenograft Models Market
11.2.7.4.1 Spain Patient Derived Xenograft Models Market by Product Type
11.2.7.4.2 Spain Patient Derived Xenograft Models Market by Tumor Type
11.2.7.4.3 Spain Patient Derived Xenograft Models Market by Application
11.2.7.4.4 Spain Patient Derived Xenograft Models Market by End-Users
11.2.7.5 United Kingdom Patient Derived Xenograft Models Market
11.2.7.5.1 United Kingdom Patient Derived Xenograft Models Market by Product Type
11.2.7.5.2 United Kingdom Patient Derived Xenograft Models Market by Tumor Type
11.2.7.5.3 United Kingdom Patient Derived Xenograft Models Market by Application
11.2.7.5.4 United Kingdom Patient Derived Xenograft Models Market by End-Users
11.2.7.6 Rest of Europe Patient Derived Xenograft Models Market
11.2.7.6.1 Rest of Europe Patient Derived Xenograft Models Market by Product Type
11.2.7.6.2 Rest of Europe Patient Derived Xenograft Models Market by Tumor Type
11.2.7.6.3 Rest of Europe Patient Derived Xenograft Models Market by Application
11.2.7.6.4 Rest of Europe Patient Derived Xenograft Models Market by End-Users
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Patient Derived Xenograft Models Market Overview
11.3.2 Asia-Pacific Patient Derived Xenograft Models Market Forecasts and Analysis
11.3.3 Asia-Pacific Patient Derived Xenograft Models Market Forecasts and Analysis - By Product Type
11.3.4 Asia-Pacific Patient Derived Xenograft Models Market Forecasts and Analysis - By Tumor Type
11.3.5 Asia-Pacific Patient Derived Xenograft Models Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Patient Derived Xenograft Models Market Forecasts and Analysis - By End-Users
11.3.7 Asia-Pacific Patient Derived Xenograft Models Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Patient Derived Xenograft Models Market
11.3.7.1.1 Australia Patient Derived Xenograft Models Market by Product Type
11.3.7.1.2 Australia Patient Derived Xenograft Models Market by Tumor Type
11.3.7.1.3 Australia Patient Derived Xenograft Models Market by Application
11.3.7.1.4 Australia Patient Derived Xenograft Models Market by End-Users
11.3.7.2 China Patient Derived Xenograft Models Market
11.3.7.2.1 China Patient Derived Xenograft Models Market by Product Type
11.3.7.2.2 China Patient Derived Xenograft Models Market by Tumor Type
11.3.7.2.3 China Patient Derived Xenograft Models Market by Application
11.3.7.2.4 China Patient Derived Xenograft Models Market by End-Users
11.3.7.3 India Patient Derived Xenograft Models Market
11.3.7.3.1 India Patient Derived Xenograft Models Market by Product Type
11.3.7.3.2 India Patient Derived Xenograft Models Market by Tumor Type
11.3.7.3.3 India Patient Derived Xenograft Models Market by Application
11.3.7.3.4 India Patient Derived Xenograft Models Market by End-Users
11.3.7.4 Japan Patient Derived Xenograft Models Market
11.3.7.4.1 Japan Patient Derived Xenograft Models Market by Product Type
11.3.7.4.2 Japan Patient Derived Xenograft Models Market by Tumor Type
11.3.7.4.3 Japan Patient Derived Xenograft Models Market by Application
11.3.7.4.4 Japan Patient Derived Xenograft Models Market by End-Users
11.3.7.5 South Korea Patient Derived Xenograft Models Market
11.3.7.5.1 South Korea Patient Derived Xenograft Models Market by Product Type
11.3.7.5.2 South Korea Patient Derived Xenograft Models Market by Tumor Type
11.3.7.5.3 South Korea Patient Derived Xenograft Models Market by Application
11.3.7.5.4 South Korea Patient Derived Xenograft Models Market by End-Users
11.3.7.6 Rest of Asia-Pacific Patient Derived Xenograft Models Market
11.3.7.6.1 Rest of Asia-Pacific Patient Derived Xenograft Models Market by Product Type
11.3.7.6.2 Rest of Asia-Pacific Patient Derived Xenograft Models Market by Tumor Type
11.3.7.6.3 Rest of Asia-Pacific Patient Derived Xenograft Models Market by Application
11.3.7.6.4 Rest of Asia-Pacific Patient Derived Xenograft Models Market by End-Users
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Patient Derived Xenograft Models Market Overview
11.4.2 Middle East and Africa Patient Derived Xenograft Models Market Forecasts and Analysis
11.4.3 Middle East and Africa Patient Derived Xenograft Models Market Forecasts and Analysis - By Product Type
11.4.4 Middle East and Africa Patient Derived Xenograft Models Market Forecasts and Analysis - By Tumor Type
11.4.5 Middle East and Africa Patient Derived Xenograft Models Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Patient Derived Xenograft Models Market Forecasts and Analysis - By End-Users
11.4.7 Middle East and Africa Patient Derived Xenograft Models Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Patient Derived Xenograft Models Market
11.4.7.1.1 South Africa Patient Derived Xenograft Models Market by Product Type
11.4.7.1.2 South Africa Patient Derived Xenograft Models Market by Tumor Type
11.4.7.1.3 South Africa Patient Derived Xenograft Models Market by Application
11.4.7.1.4 South Africa Patient Derived Xenograft Models Market by End-Users
11.4.7.2 Saudi Arabia Patient Derived Xenograft Models Market
11.4.7.2.1 Saudi Arabia Patient Derived Xenograft Models Market by Product Type
11.4.7.2.2 Saudi Arabia Patient Derived Xenograft Models Market by Tumor Type
11.4.7.2.3 Saudi Arabia Patient Derived Xenograft Models Market by Application
11.4.7.2.4 Saudi Arabia Patient Derived Xenograft Models Market by End-Users
11.4.7.3 U.A.E Patient Derived Xenograft Models Market
11.4.7.3.1 U.A.E Patient Derived Xenograft Models Market by Product Type
11.4.7.3.2 U.A.E Patient Derived Xenograft Models Market by Tumor Type
11.4.7.3.3 U.A.E Patient Derived Xenograft Models Market by Application
11.4.7.3.4 U.A.E Patient Derived Xenograft Models Market by End-Users
11.4.7.4 Rest of Middle East and Africa Patient Derived Xenograft Models Market
11.4.7.4.1 Rest of Middle East and Africa Patient Derived Xenograft Models Market by Product Type
11.4.7.4.2 Rest of Middle East and Africa Patient Derived Xenograft Models Market by Tumor Type
11.4.7.4.3 Rest of Middle East and Africa Patient Derived Xenograft Models Market by Application
11.4.7.4.4 Rest of Middle East and Africa Patient Derived Xenograft Models Market by End-Users
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Patient Derived Xenograft Models Market Overview
11.5.2 South and Central America Patient Derived Xenograft Models Market Forecasts and Analysis
11.5.3 South and Central America Patient Derived Xenograft Models Market Forecasts and Analysis - By Product Type
11.5.4 South and Central America Patient Derived Xenograft Models Market Forecasts and Analysis - By Tumor Type
11.5.5 South and Central America Patient Derived Xenograft Models Market Forecasts and Analysis - By Application
11.5.6 South and Central America Patient Derived Xenograft Models Market Forecasts and Analysis - By End-Users
11.5.7 South and Central America Patient Derived Xenograft Models Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Patient Derived Xenograft Models Market
11.5.7.1.1 Brazil Patient Derived Xenograft Models Market by Product Type
11.5.7.1.2 Brazil Patient Derived Xenograft Models Market by Tumor Type
11.5.7.1.3 Brazil Patient Derived Xenograft Models Market by Application
11.5.7.1.4 Brazil Patient Derived Xenograft Models Market by End-Users
11.5.7.2 Argentina Patient Derived Xenograft Models Market
11.5.7.2.1 Argentina Patient Derived Xenograft Models Market by Product Type
11.5.7.2.2 Argentina Patient Derived Xenograft Models Market by Tumor Type
11.5.7.2.3 Argentina Patient Derived Xenograft Models Market by Application
11.5.7.2.4 Argentina Patient Derived Xenograft Models Market by End-Users
11.5.7.3 Rest of South and Central America Patient Derived Xenograft Models Market
11.5.7.3.1 Rest of South and Central America Patient Derived Xenograft Models Market by Product Type
11.5.7.3.2 Rest of South and Central America Patient Derived Xenograft Models Market by Tumor Type
11.5.7.3.3 Rest of South and Central America Patient Derived Xenograft Models Market by Application
11.5.7.3.4 Rest of South and Central America Patient Derived Xenograft Models Market by End-Users

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. PATIENT DERIVED XENOGRAFT MODELS MARKET, KEY COMPANY PROFILES
13.1. CROWN BIOSCIENCE INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. WUXI APPTEC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. CHAMPIONS ONCOLOGY, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. THE JACKSON LABORATORY
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ONCODESIGN
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. EPO BERLIN-BUCH GMBH
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SHANGHAI LIDE BIOTECH CO., LTD
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. XENTECH
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ENVIGO
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Crown Bioscience Inc.
2. WuXi AppTec
3. Champions Oncology, Inc.
4. The Jackson Laboratory
5. Oncodesign
6. Charles River Laboratories International, Inc.
7. EPO Berlin-Buch GmBH
8. Shanghai LIDE Biotech Co., Ltd
9. Xentech
10. Envigo
TIPRE00021693
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount